Teclistamab
Showing 1 - 20 of 20
Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- +2 more
-
Miami, FloridaUniversity of Miami
Oct 20, 2023
Myeloma Multiple Trial (Off Drug Surveillance)
Not yet recruiting
- Myeloma Multiple
- Off Drug Surveillance
- (no location specified)
Jun 27, 2023
Multiple Myeloma Trial (Bone marrow sampling)
Not yet recruiting
- Multiple Myeloma
- Bone marrow sampling
- (no location specified)
Jul 11, 2023
Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- +2 more
- (no location specified)
Oct 6, 2022
Relapsed or Refractory Multiple Myeloma Trial in Dummy (Teclistamab)
Available
- Relapsed or Refractory Multiple Myeloma
- Teclistamab
-
Dummy, France
- +2 more
Aug 10, 2022
Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)
Recruiting
- Multiple Myeloma
- Teclistamab (Tec)
- +4 more
-
Berlin, Germany
- +8 more
Jan 19, 2023
High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)
Not yet recruiting
- High-Risk de Novo Multiple Myeloma
- Daratumumab
- +5 more
-
Badalona, Spain
- +9 more
Apr 27, 2023
Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
Recruiting
- Multiple Myeloma
-
Annecy, France
- +19 more
Sep 28, 2023
Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Teclistamab
- +5 more
-
Birmingham, Alabama
- +26 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Teclistamab, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- Lenalidomide
-
Melbourne, Australia
- +13 more
Feb 7, 2022
High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Teclistamab, Lenalidomide,
Recruiting
- High-risk Smoldering Multiple Myeloma
- +2 more
- Teclistamab
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Aug 11, 2022
Hematologic Malignancies Trial in Japan (Teclistamab)
Recruiting
- Hematologic Malignancies
- Teclistamab
-
Chiba, Japan
- +14 more
Aug 11, 2022
Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, PD-1 Inhibitor)
Recruiting
- Relapsed/ Refractory Multiple Myeloma
- Talquetamab
- +2 more
-
Denver, Colorado
- +19 more
Jan 27, 2023
Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT
Not yet recruiting
- Multiple Myeloma
- Dara-VRd intensification, Dara-R maintenance
- +4 more
- (no location specified)
Dec 13, 2022
Hematological Malignancies Trial in Worldwide (Teclistamab)
Recruiting
- Hematological Malignancies
- Teclistamab
-
Birmingham, Alabama
- +80 more
Jan 27, 2023
Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Teclistamab, Pomalidomide, Bortezomib)
Recruiting
- Relapsed or Refractory Multiple Myeloma
- Teclistamab
- +4 more
-
Berkeley, California
- +188 more
Jan 27, 2023
Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)
Recruiting
- Multiple Myeloma
- Teclistamab
- +3 more
-
Tucson, Arizona
- +189 more
Jan 27, 2023